About The Hepatitis Fund

We provide grants, build financing partnerships, provide technical support on health financing, and advocate for increased national and international funding to eliminate viral hepatitis now.

We allocate resources based on operational excellence, careful impact assessment and the use of best grant-making practices.

Learn more about our Strategic Plan 2022 – 2027 and 2021 Activity Report.

THF Global Ambassador

The Hepatitis Fund

Rt Hon. Helen Clark, former Prime Minister of New Zealand and former Administrator of UNDP, is the Global Ambassador of The Hepatitis Fund.

Helen Clark was Prime Minister of New Zealand from 1999–2008 and a Member of Parliament for 27 years. She advocated strongly for economic and social justice, sustainability and climate action, and for multilateralism. Helen served two terms as Administrator of the United Nations Development Programme (UNDP) and as Chair of the United Nations Development Group from 2009-2017. Earlier, Helen taught in the Political Studies Department of the University of Auckland, from which she had graduated with BA and MA (Hons) degrees.

Helen advocates for sustainable development, climate action, gender equality and women’s leadership, peace and justice, and action on pressing global health issues. In July 2020, she was appointed by the Director-General of the World Health Organisation as Co-Chair of the Independent Panel for Pandemic Preparedness and Response. She chairs the boards of the Extractive Industries Transparency Initiative, the Partnership for Maternal, Newborn and Child Health, and other public good organisations and initiatives.

Board of directors

Gregg H. Alton


More info

Manal El-Sayed

More info

Charles Gore

More info

Gottfried Hirnschall

More info

Kenneth Kabagambe

Hepatitis Advocate, Uganda

More info

Lynn Lau


More info

Carol Tissot

Secretary and General Counsel

More info

Executive team

Finn Jarle Rode

Executive Director

More info

Capucine Penicaud

Director Programme and Partnerships

Maria Carolina Salazar

Senior Programme Officer, Grants and M&E

Benedetta Nirta

Fundraising Manager

More info

Francesca Da Ros

Communications Manager

Advisory Council

The scope of Tour activities spans numerous hepatitis prevention and care interventions that target different populations in a wide range of geographical settings. Our Advisory Council members are experts in key programmatic aspects of hepatitis prevention and care and are representative of the key populations affected by hepatitis and regions heavily affected by hepatitis.

Joan Block

Retired executive director, Hepatitis B Foundation

Saeed Hamid

Co-chair, Coalition to Eradicate Viral Hepatitis in Asia Pacific

Homie Razavi

Executive director, Center for Disease Analysis Foundation

Lewis Roberts

Director, Gastroenterology and Hepatology Cancer Center at the Mayo Clinic

Shin Young-Soo

Director emeritus, WHO Western Pacific Regional Office

Su Wang

Medical Director, Viral Hepatitis Programs

ZeShan Foundation

Steering and Oversight Committees

We thank members of the EndHep2030 steering committee and oversight committee who supported the emergence of this initiative.

We thank our past President and co-Founder, Mr Wangsheng LI, for leading The Hepatitis Fund through numerous changes and challenges these past two and a half years. 

Oversight Committee members

The Oversight Committee was active from November 2017 – December 2019. It was created as the managing body for EndHep2030 as an RPA-sponsored project.

Steering Committe members

The Steering Committee was created to stand up the EndHep2030 project. It was in commission from November 2016 through October 2017. The Steering Committee accomplished its mandate upon the launch of EndHep2030 in 2017.

Manal El-Sayed

Professor of Pediatrics at Ain Shams University.

Marc Bulterys

Director WHO Global Hepatitis Programme

Charles Gore

Executive Director Medicines Patent Pool

Jinlin Hou

Chairman and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University.

Rana Hajjeh

Director Department of Communicable Disease Prevention and Control, WHO Regional Office for the Eastern Mediterranean

Paul Kuehnert

Vice President, Program Robert Woods Johnson Foundation

Ying-ru Jacqueline Lo

Team Lead HIV, Hepatitis & STD, WHO Western Pacific Regional Office

Lillian Lou

Executive Director The John C. Martin Foundation

Tony Lee

Director and Partner Social Sector Practice, McKinsey & Company

Judith Monroe

president and CEO of the CDC Foundation.

Nicole M. Smith

Associate Director for Policy & Communication for the Division of Viral Hepatitis at the U.S. CDC.

Isabelle Mayer-Andrieux

Viral Hepatitis Advisor Médecins Sans Frontières

Annette Sohn

Executive Director TreatAsia, amfAR

Kathrine Meyers

Director for China Program Aaron Diamond AIDS Research Center at the Rockefeller University

Mike van der Ven

Director Pivotal Ventures, Bill and Melinda Gates Foundation

Nick Walsh

Medical Officer (Viral Hepatitis) WHO Consultant

Stefan Wiktor

Founding Director (retired) WHO Global Hepatitis Programme

John Ward

Director Coalition for Global Hepatitis Elimination

David Wilson

Program director, World Bank’s Health, Population and Nutrition global practice.